About: Hepatitis
Standardised data is needed to decode mystery hepatitis in children
While the rate of diagnoses of hepatitis cases of unknown origin among children has started to decrease, scientists' understanding of the infections remains “mixed” - in part, due to a lack of standardisation of data collection across the globe.
The severity of mysterious hepatitis among children “very unusual”
Cases of hepatitis of unknown origin among children have now been recorded in 20 countries in Europe. While hepatitis of unknown origin is reported every year, the severity of cases this time is “very unusual”, medical experts say.
Slow path towards elimination of viral hepatitis in Europe
Despite the UN aiming to eliminate viral hepatitis by 2030, a report published on Wednesday (15 June) has found that around a quarter of EU/EEA countries don’t have action plans or strategies for the prevention and control of the disease.
Adenovirus, COVID-19 examined as possible cause for mysterious hepatitis
As acute hepatitis cases of unknown origin continue to grow across the globe, the investigation into its origin is ongoing. While the leading hypothesis is adenovirus, the link to COVID-19 is also being looked at.
ECDC: Around 95 cases of mysterious child hepatitis in 15 EU countries
Fifteen EU countries have reported cases of acute hepatitis of unknown origin in children, while health authorities continue trying to figure out the cause.
Cases of unknown hepatitis strain reported among children in EU
Cases of acute hepatitis of unknown origin were reported among children in Denmark, Ireland, the Netherlands, Spain and the UK, the European Centre for Disease Control said on Tuesday (19 April).
EU countries need to do their homework to eliminate hepatitis by 2030
The world is on a mission to eliminate viral hepatitis as a major public health threat by 2030. But the World Health Organisation has warned that despite positive progress in recent years, “there is still a long way to go”. InfographicPromoted content
Why we need to build online communities for patients with advanced non-melanoma skin cancer?
With the Global Non-Melanoma Skin Cancer (NMSC) Awareness Day nearing on the 13th of June, the European Cancer Patient Coalition (ECPC) launched a NMSC Online Community-Building Toolkit.
Professor: EU should establish roadmap for hepatitis C virus elimination
Eliminating hepatitis C should be tackled at EU level by establishing a clear political road map and mobilising public and private funding, Angelos Hatzakis told EURACTIV in an interview.
The fight for viral hepatitis C elimination
The hepatitis C virus is a global public health threat with significant morbidity and mortality, and within Europe, the WHO's Eastern Mediterranean Region and the European Region have the highest reported prevalence.
MEPs step up action to protect terminally ill workers in the EU
A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.
Commission sees biotech as ‘integral part’ of EU healthcare
Biotechnology-derived medicinal products are fully part of EU healthcare but there are still many unknowns which call for adequate controls, the European Commission told EURACTIV.
Health matters should supersede European bureaucracy
European red tape should not be an obstacle to effective healthcare. For patients with diseases like sarcoma, waiting means suffering and often avoidable death, writes Marlene Mizzi.
How Italy and France take on rare sarcoma cancers
EU member states are exploring ways to effectively tackle the rising occurrence and complex nature of rare cancers known as sarcomas.
Complex sarcoma cancer needs an overall strategy, report says
The diverse nature of rare cancers like sarcomas poses severe challenges to the medical community and policy-makers who need to seek a holistic approach, according to a report.
Families cannot tackle childhood obesity alone, EU study says
The family environment is not able to overcome childhood obesity without governmental support, a new report has found.
Andriukaitis: ‘Rare cancers present a particular challenge’
The European Commission’s priority when tackling rare cancers such as sarcomas is to ensure European Reference Networks (ERNS) are put in place so that all patients have access to the best expertise available in the EU, Vytenis Andriukaitis told Euractiv.com in an interview.
Rare cancers: A headache for policymakers
The complexity of diagnosing and treating rare forms of cancers like sarcomas can be addressed by a multi-level approach and better coordination among member states, insist experts in the field.
Rare cancers: Cracking the code
The growing number of cases of rare diseases has raised eyebrows in the EU and policymakers are now exploring ways to understand and tackle the complexity of the phenomenon.
Poverty and tobacco carry similar health risks, study finds
People on the bottom rung of the socioeconomic ladder may live two years less on average than those at the top, according to a large-scale study published Wednesday (31 January) in the British journal The Lancet.
Drugmaker Novo Nordisk bets $145 mln on post-Brexit UK science
The world's largest producer of diabetes drugs has invested millions in a new research centre at the University of Oxford despite Brexit and a possible move of the European Medicines Agency from London.
Breast implant victims win payout from German safety body
A French court on Friday ordered German safety certifier TUV to pay €60 million in compensation to 20,000 women who received defective breast implants that the group had approved.
Polish pollution akin to smoking 4,000 cigarettes a year
Air pollution made headlines in Poland this week but the issue was not the only thing to worry Poles, as lack of transparency and corruption in government once again reared their heads. EURACTIV Poland reports.